Researchers test CBD's ability to restore functional autophagy, reduce inflammation and positively enhance muscle function.
Both children and adults that received CBD, in conjunction with their traditional anti-epileptic medications, experienced a significant decrease in drop seizures during the trial with minimal adverse effects.
Cannabis has shown to have anti-inflammatory and anti-hyperalgesia (lowering of pain response) properties, but the exact plant components causing these effects were the target of this study.
Researchers are conducting studies to examine the effect of CBD when injected directly in the hippocampus area of the brain and whether CBD could be a viable treatment therapy for depression.
A group of researchers from the United States, Canada and Italy conducted a study on rats to determine if CBD could be a viable treatment option for neuropathic pain conditions.
The administration of the CBD treatments was able to reverse the negative effects induced by iron on the brain, including cell death, and demonstrated that cannabidiol has neuroprotective properties through its ability to prevent cell death.
The results of the study demonstrated to researchers that CBD was able to realign the brain to normal levels and possibly reduce psychotic symptoms.
“Cannabidiol may not only be a faster-acting antidepressant than conventional drugs but also improve the response to such drugs when taken in combination with them.”
CBD has previously demonstrated immunosuppressant properties which encouraged a new study examining the effectiveness of CBD as a treatment therapy option for MS patients.